Elderly Donors for HCV+ Versus Non-HCV Recipients: Patient Survival Following Liver Transplantation

Transplantation Proceedings

Volumn 40, Issue 3, 2008, Pages 792-796

  Boin, I F S F ^a   Ataide, E C ^a   Leonardi, M I ^a   Stucchi, R ^a   Seva Pereira T ^a   Pereira, I W ^a   Cardoso, A R ^a   Caruy, C A ^a   Luzo, A ^a   Leonardi, L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; GRAFT VERSUS HOST REACTION; HEPATITIS C; HUMAN; ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ADULT; AGE FACTORS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; SURVIVORS; TISSUE DONORS;

EID: 42949157466     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.02.069     Document Type: Article

References (28)

1. Adam R., McMaster P., O'Grady J.G., et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 9 (2003) 1231
2. Berenguer M., Lopez-Labrador F.X., and Wright T.L. Hepatitis C and liver transplantation. J Hepatol 35 (2001) 666
3. Wiesner R.H., Sorrell M., and Villamil F. Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 9 suppl (2003) S1
4. Prieto M., Berenguer M., Rayon J.M., et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 29 (1999) 250
5. Gane E.J., Portmann B.C., Naoumov N.V., et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334 (1996) 815
6. Feray C., Caccamo L., Alexander G.J., et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 117 (1999) 619
7. Forman L.M., Lewis J.D., Berlin J.A., et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122 (2002) 889
8. Berenguer M., Prieto M., San Juan F., et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 36 (2002) 202
9. Futagawa Y., Terasaki P.I., Waki K., et al. No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data. Am J Transplant 6 (2006) 1398
10. Berenguer M., Ferrell L., Watson J., et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32 (2000) 673
11. Rodriguez-Luna H., and Douglas D.D. Natural history of hepatitis C following liver transplantation. Curr Opin Infect Dis 17 (2004) 363
12. Roche B., and Samuel D. Aspects of hepatitis C virus infection relating to liver transplantation. Eur J Gastroenterol Hepatol 18 (2006) 313
13. Busquets J., Xiol X., Figueras J., et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 71 (2001) 1765
14. Pirenne J., Declauwe H., and Aerts R. Patients transplanted for hepatitis C should not receive organs from older donors. Hepatology 34 (2001) 409A
15. Takada Y., Haga H., Ito T., et al. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients. Transplantation 81 (2006) 350
16. Feng S., Goodrich N.P., Bragg-Gresham J.L., et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6 (2006) 783
17. Maluf D.G., Edwards E., and Kauffman H.M. Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?. Transplantation 82 (2006) 1653
18. Charlton M. Recurrence of hepatitis C infection: where are we now?. Liver Transpl 11 suppl 1 (2005) S57
19. Carmiel-Haggai M., Fiel M.I., Gaddipati H.C., et al. Recurrent hepatitis C after re-transplantation: factors affecting graft and patient outcome. Liver Transpl 11 (2005) 1567
20. Wali M., Harrison R.F., Gow P.J., et al. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 51 (2002) 248
21. Machicao V.I., Bonatti H., Krishna M., et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 77 (2004) 84
22. Walter T., Dumortier J., Guillaud O., et al. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center. Liver Transpl 13 (2007) 294
23. Bueno F.S., Ortiz M.L., Bermejo J., et al. Prognostic factors for hepatitis C recurrence in patients undergoing orthotopic liver transplantation. Transpl Immunol 17 (2006) 47
24. Burak K.W., Kremers W.K., Batts K.P., et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 8 (2002) 362
25. Lake J.R., Shorr J.S., Steffen B.J., et al. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 5 (2005) 549
26. Berenguer M., Ferrell L., Watson J., et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32 (2000) 673
27. Kuo A., and Terrault N.A. Management of hepatitis C in liver transplant recipients. Am J Transplant 6 (2006) 449
28. McCluskey A.S., Karkouti K., Wijeysundera D.N., et al. Derivation of a risk index for the prediction of massive blood transfusion in liver transplantation. Liver Transpl 12 (2006) 1584